These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11485658)

  • 1. Opportunistic infections in persons with HIV or other immunocompromising conditions.
    Kaplan JE; Sepkowitz K; Masur H; Sirisanthana T; Russo M; Chapman L
    Emerg Infect Dis; 2001; 7(3 Suppl):541. PubMed ID: 11485658
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference.
    European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel
    AIDS; 2011 Feb; 25(4):399-409. PubMed ID: 21139491
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C as an opportunistic infection in HIV patients.
    Clarke B
    Lancet Infect Dis; 2001 Aug; 1(1):3. PubMed ID: 11871408
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
    Tan IL; McArthur JC
    Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumocystis pneumonia.
    del Rio C; Barragan M; Franco-Paredes C
    N Engl J Med; 2004 Sep; 351(12):1262-3. PubMed ID: 15371588
    [No Abstract]   [Full Text] [Related]  

  • 7. Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda.
    Rubaihayo J; Tumwesigye NM; Konde-Lule J; Makumbi F
    BMC Public Health; 2016 Aug; 16(1):766. PubMed ID: 27515983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasmosis-associated deaths among Human Immunodeficiency Virus-infected persons in the United States, 1992-1998.
    Jones JL; Sehgal M; Maguire JH
    Clin Infect Dis; 2002 Apr; 34(8):1161. PubMed ID: 11915013
    [No Abstract]   [Full Text] [Related]  

  • 9. The continuing challenge of opportunistic infections.
    Scoular A
    J HIV Ther; 2002 Feb; 7(1):1. PubMed ID: 11956496
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study.
    Shenoy N; Ramapuram JT; Shenoy A; Ahmed J; Srikant N
    J Int Assoc Provid AIDS Care; 2017; 16(3):309-311. PubMed ID: 28050923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.
    Gaitán-Cepeda LA; Sánchez-Vargas O; Castillo N
    Int J STD AIDS; 2015 Aug; 26(9):625-32. PubMed ID: 25156369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic infection associated to HIV/AIDS in Nepal.
    Arijit G; Shalini C
    Med J Malaysia; 2007 Mar; 62(1):88. PubMed ID: 17682586
    [No Abstract]   [Full Text] [Related]  

  • 13. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy.
    Grulich AE
    AIDS Read; 2000 Jun; 10(6):341-6. PubMed ID: 10881365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.
    De Cock KM; Marston B
    Am J Respir Crit Care Med; 2005 Jul; 172(1):3-4. PubMed ID: 15980107
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of infectious skin manifestations in the era of highly active antiretroviral therapy.
    Hengge UR; Franz B; Goos M
    AIDS; 2000 May; 14(8):1069-70. PubMed ID: 10853995
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.